Note 7.

Debt

The components of debt were as follows ($000):

June 30,	2014			2013
Line of credit, interest at LIBOR, as defined, plus 1.75% and 1.25%, respectively	$	154,000		$	111,000
Term loan, interest at LIBOR, as defined, plus 1.25%	$	85,000			-
Yen denominated line of credit, interest at LIBOR, as defined, plus 0.625%		2,960			3,036
Total debt		241,960			114,036
Current portion of long-term debt		(20,000	)		-
Long-term debt, less current portion	$	221,960		$	114,036

In September 2013, the Company amended and restated its existing credit agreement. The Second Amended and Restated Credit Agreement (the “Amended Credit Facility”) provides for a revolving credit facility of $225 million (increased from $140 million), as well as a $100 million Term Loan. The Term Loan shall be re-paid in consecutive quarterly principal payments on the first business day of each January, April, July and October, with the first payment commencing on October 1, 2013, as follows: (i) twenty consecutive quarterly installments of $5 million and (ii) a final installment of all remaining principal due and payable on the maturity date. The Amended Credit Facility is unsecured, but is guaranteed by each existing and subsequently acquired or organized wholly-owned domestic subsidiary of the Company. The Company has the option to request an increase to the size of the Amended Credit Facility in an aggregate additional amount not to exceed $100 million. The Amended Credit Facility has a five-year term through September 2018 and has an interest rate of LIBOR, as defined in the agreement, plus 0.75% to 1.75% based on the Company’s ratio of consolidated indebtedness to consolidated EBITDA. Additionally, the facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of June 30, 2014, the Company was in compliance with all financial covenants under its Amended Credit Facility.

In conjunction with entering into the Amended Credit Facility, the Company incurred approximately $1.0 million of deferred financing costs which are being amortized over the term of the agreement. As a result of the overall increase in borrowing capacity, existing deferred financing costs at the time of the amendment of $0.5 million are also being amortized over the term of the Amended Credit Facility.

The Company’s Yen denominated line of credit is a 500 million Yen facility that has a five-year term through June 2016 and has an interest rate equal to LIBOR, as defined in the loan agreement, plus 0.625% to 1.50%. Additionally, the facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of June 30, 2014, the Company was in compliance with all covenants under the Yen facility.

The Company had aggregate availability of $71.0 million and $29.8 million under its lines of credit as of June 30, 2014 and 2013, respectively. The amounts available under the Company’s lines of credit are reduced by outstanding letters of credit. As of June 30, 2014 and 2013, total outstanding letters of credit supported by the credit facilities were $1.9 million and $1.3 million, respectively.

The weighted-average interest rate of total borrowings for the years ended June 30, 2014 and 2013 was 1.8% and 1.4%, respectively. The weighted-average of total borrowings for the fiscal years ended June 30, 2014 and 2013 was $222.6 million and $82.5 million, respectively.

The Company has a line of credit facility with a Singapore bank which permits maximum borrowings in the local currency of approximately $0.3 million and $0.4 million for the fiscal years ended June 30, 2014 and 2013. Borrowings are payable upon demand with interest charged at the rate of 1.00% above the bank’s prevailing prime lending rate. The interest rate was 5.25% at June 30, 2014 and June 30, 2013. At June 30, 2014 and 2013, there were no outstanding borrowings under this facility.

There are no interim maturities or minimum payment requirements related to the credit facilities before their respective expiration dates. Interest and commitment fees paid during the fiscal year ended June 30, 2014 and 2013 was $4.2 million and $1.1 million, respectively, and was immaterial for fiscal year 2012.